Jake Bauer brings more than 15 years of biopharma industry experience. He is currently responsible for corporate and business development, program management, portfolio strategy, alliance management, and corporate strategy functions. From July 2014 to April 2018, he also led the finance, accounting, information technology, facilities, corporate communications, and investor relations functions as senior vice president, finance and corporate development.
He joined MyoKardia from Ablexis, LLC, where he was vice president, business operations and head of corporate development. At Ablexis, he led the development and implementation of the company’s corporate strategy and business development activities and oversaw business operations. Prior to Ablexis Mr. Bauer was a principal at Third Rock Ventures, where he was actively involved in a variety of leading biopharmaceutical companies including Agios, CytomX, Global Blood Therapeutics and Zafgen. Prior to Third Rock Ventures, Mr. Bauer served in roles in the investment group at Royalty Pharma, the business development group at Endo Pharmaceuticals, and was previously a management consultant at Putnam Associates.
Mr. Bauer holds a B.Sc. in biology and a B.A. in economics from Duke University and an M.B.A. from Harvard Business School.